Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
118.82x
As of Dec 30, 2022
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Dec 30, 2022 | 118.82x |
| Dec 29, 2022 | 114.86x |
| Dec 28, 2022 | 110.90x |
| Dec 27, 2022 | 114.34x |
| Dec 23, 2022 | 124.11x |
| Dec 22, 2022 | 121.46x |
| Dec 21, 2022 | 118.30x |
| Dec 20, 2022 | 113.81x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison